In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi

The Journal of Antimicrobial Chemotherapy
A LiendoJ A Urbina

Abstract

We investigated the in-vitro antiproliferative effects and mechanism of action of both enantiomers of the bis-triazole derivative ICI 195,739 against epimastigotes and amastigotes of Trypanosoma cruzi, the aetiological agent of Chagas' disease. It has recently been shown that the R(+) enantiomer, D0870, can induce radical parasitological cure in murine models of the acute and chronic forms of the disease. D0870 dose-dependently affected the growth rate of the epimastigote form (IC50 = 0.1 microM; MIC = 1-3 microM). The S(-) enantiomer was much less active (IC50 = 3 microM). Growth arrest and cell lysis induced by D0870 coincided with the complete depletion of endogenous 4,14-desmethyl sterols and their replacement by 4,14-trimethyl and dimethyl sterols. The S(-) enantiomer produced qualitatively similar changes but to a lesser extent. D0870 inhibited the incorporation of radioactivity from [2-14C]acetate into the epimastigote's 4,14-desmethyl sterols with an IC50 of 50 nM while the corresponding concentration for the S(-) enantiomer was 3 microM. D0870 eradicated the intracellular (amastigote) form of the parasite from cultured Vero cells at 10 nM; a 100-fold higher concentration of the S(-) enantiomer was required to produce a...Continue Reading

Citations

May 29, 2004·International Journal of Antimicrobial Agents·Luciana R GarzoniJulio A Urbina
Sep 12, 2001·Molecular and Biochemical Parasitology·B M JoubertF S Buckner
Dec 7, 2002·Molecular and Biochemical Parasitology·Julio A UrbinaRenee Lira
Dec 10, 1999·Molecular and Biochemical Parasitology·A LiendoJ A Urbina
Jan 1, 2003·International Journal of Antimicrobial Agents·Julio A UrbinaAlvaro J Romanha
May 8, 2007·Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·Marina V BragaWanderley de Souza
Aug 22, 2007·Antimicrobial Agents and Chemotherapy·Simon B CammererIan H Gilbert
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Paulo Marcos da Matta GuedesMaria Terezinha Bahia
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Silvia Orenes LorenteIan H Gilbert
May 26, 2011·Expert Review of Anti-infective Therapy·Paulo M M GuedesJoão S Silva
Jul 18, 2006·International Journal of Antimicrobial Agents·Miriam RolónFrancisco Malpartida
Jul 28, 2005·Bioorganic & Medicinal Chemistry·Silvia Orenes LorenteIan H Gilbert
Apr 26, 2005·Bioorganic & Medicinal Chemistry·Silvia Orenes LorenteIan H Gilbert
Jan 18, 2007·Annals of Tropical Medicine and Parasitology·A Moncayo, M I Ortiz Yanine
Jan 2, 2013·International Journal for Parasitology. Drugs and Drug Resistance·Frederick S Buckner, Julio A Urbina
Jul 15, 2011·Enzyme Research·Simone Guedes CalderanoMaria Carolina Elias
Jun 10, 2000·Memórias do Instituto Oswaldo Cruz·J A Urbina
Oct 17, 2003·Journal of Medicinal Chemistry·Filippo MagaraciIan H Gilbert
Aug 23, 2002·Journal of Medicinal Chemistry·Eleonora ElhalemJuan B Rodriguez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.